BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-467@pharmaconomics
DTSTAMP:20260707T033816Z
DTSTART;VALUE=DATE:20251231
DTEND;VALUE=DATE:20260101
SUMMARY:INCY Phase 1 — INCA033989 (estimated date)
DESCRIPTION:Phase 1 trial results for INCA033989 in essential thrombocythemia / myelofibrosis are due ~ Dec 31\, 2025. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/879169/000087916926000006/incy-q42025xexx991.htm\n\nTrack it: https://pharmaconomics.com/e/467
URL:https://pharmaconomics.com/e/467
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:INCY catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR